219 related articles for article (PubMed ID: 16028759)
1. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
Im SH; Oh CW; Kwon OK; Kim JE; Han DH
J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya disease concurrent with Graves' disease treated by direct bypass: clinical features and treatment strategies.
Ryu B; Kawamata T; Yamaguchi K; Kawashima A; Ono M; Okada Y
Acta Neurochir (Wien); 2015 Jul; 157(7):1095-102. PubMed ID: 25929211
[TBL] [Abstract][Full Text] [Related]
3. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Ohba S; Nakagawa T; Murakami H
Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
[TBL] [Abstract][Full Text] [Related]
5. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions.
Narisawa A; Fujimura M; Tominaga T
Clin Neurol Neurosurg; 2009 Feb; 111(2):123-6. PubMed ID: 18995956
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.
Zhang W; Wang X; Wang Z; Shang J; Wang H; Yin G
World Neurosurg; 2016 Sep; 93():365-70. PubMed ID: 27350298
[TBL] [Abstract][Full Text] [Related]
8. Reversible occlusion of donor vessel caused by mouth opening after superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya patients.
Katsuta T; Abe H; Miki K; Inoue T
J Neurosurg; 2015 Sep; 123(3):670-5. PubMed ID: 25909570
[TBL] [Abstract][Full Text] [Related]
9. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
10. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
11. Graves' thyrotoxicosis and Moyamoya disease.
Kushima K; Satoh Y; Ban Y; Taniyama M; Ito K; Sugita K
Can J Neurol Sci; 1991 May; 18(2):140-2. PubMed ID: 2070296
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic reserve and high-intensity transient signals in moyamoya disease.
Horn P; Lanczik O; Vajkoczy P; Daffertshofer M; Bueltmann E; Werner A; Schmiedek P; Hennerici M
Cerebrovasc Dis; 2005; 19(3):141-6. PubMed ID: 15644625
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients.
Arai N; Horiguchi T; Takahashi S; Nakahara T; Akiyama T; Jinzaki M; Yoshida K
Neurosurg Rev; 2020 Oct; 43(5):1323-1329. PubMed ID: 31444715
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache.
Okada Y; Kawamata T; Kawashima A; Yamaguchi K; Ono Y; Hori T
J Neurosurg; 2012 Mar; 116(3):672-9. PubMed ID: 22149381
[TBL] [Abstract][Full Text] [Related]
15. Concurrent moyamoya disease and Graves' thyrotoxicosis: case report and literature review.
Shen AL; Ryu SJ; Lin SK
Acta Neurol Taiwan; 2006 Jun; 15(2):114-9. PubMed ID: 16871899
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients.
Li D; Yang W; Xian P; Liu P; Bao X; Zong R; Duan L
Clin Neurol Neurosurg; 2013 Sep; 115(9):1647-52. PubMed ID: 23518423
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
